BPA Call HHSF223201610017B-75F40119F19002
Award Date 9/10/19
Potential Completion Date 12/26/22
Potential Value $15M
Federal Agency
Awardee
Ultimate Awardee
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Time and Materials
Place of Performance
Silver Spring, MD 20993, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
2
Legislative Mandate
Service Contract Act
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award from the Food and Drug Administration (FDA) is for the CDER Informatics Enterprise Service and Operation Modernization project. It is a $17,461,833.28 Blanket Purchase Agreement (BPA) call awarded to Booz Allen Hamilton Inc. under the Multiple Award Schedule (MAS) contract. The contract will provide informatics enterprise services and operations modernization support to the FDA's Center for Drug Evaluation and Research (CDER) over a 3-year period until January 2025....
- The federal contract award is for DRUG QUALITY AND SECURITY SERVICES - DQSA, issued by the Food and Drug Administration (FDA), a civilian agency. The contract was awarded to Booz Allen Hamilton Inc., a prominent management, technology, and engineering services firm, on February 10, 2021, with a ceiling value of $11,166,592.47 and an ultimate completion date of July 9, 2023. The contract was issued as a Blanket Purchase Agreement (BPA) call under the Multiple Award Schedule (MAS) contract...
- Booz Allen Hamilton Inc. was awarded a $9.5 million contract by the Department of Health and Human Services' Food and Drug Administration to provide support services relating to advanced generic drug and drug quality capabilities. This contract was awarded under the prime vendor's existing FDA Safety And Innovation Act Support Services Blanket Purchase Agreement to deliver IT consulting, business analysis, data analysis and low-code software platform services in furtherance of FDA programs...
- The Food and Drug Administration awarded a $24.9 million blanket purchase agreement (BPA) call to Booz Allen Hamilton Inc. on September 26, 2025, with an ultimate completion date of September 25, 2028. This contract, executed under the Multiple Award Schedule (MAS) vehicle, supports the FDA's modernization and streamlining of operations, with updated contract line item numbers to provide for Operations, Logistics, and Maintenance (OLM) funding. The work will be performed in West McLean,...
- The Department of Health and Human Services Food and Drug Administration awarded a $5.6 million contract to Booz Allen Hamilton Inc. to provide Drug Quality and Security Services under its Multiple Award Schedule contract vehicle. The contract calls for Booz Allen Hamilton to support the FDA's DQSA program through labor-hour services such as quality control analysis, supply chain security assessments, and technical expertise. Performance will take place in Silver Spring, Maryland over a one-year...
- The Department of Health and Human Services Food and Drug Administration awarded an $18.1 million contract to Booz Allen Hamilton Inc. to provide regulatory business information services system integration services, development, modernization and enhancement for the agency under the Multiple Award Schedule contract vehicle. Booz Allen Hamilton will deliver regulatory business information system integration support to modernize and enhance the FDA's systems over an 18-month base period of...
- This is a contract award to Booz Allen Hamilton Inc., a leading provider of management, technology, and engineering services, by the Food and Drug Administration (FDA). The contract, valued at $7,647,580.46, is a Blanket Purchase Agreement (BPA) call under a larger Regulatory Review Support Services BPA. The work to be performed includes AIRRS/CIRDS support, which likely refers to regulatory review and information systems support for the FDA. The contract is not set aside and has a period of...
- This is a federal contract award by the Food and Drug Administration (FDA) to Booz Allen Hamilton Inc., a leading management and technology services firm, for a Pharmaceutical Quality and Compliance Platform (PQCP). The $2,495,019.10 contract is a BPA Call under the Mission Oriented Business Integrated Services (MOBIS) GSA Schedule, with a period of performance through December 2019. The contract does not have a set-aside designation. Booz Allen Hamilton Inc. is the prime contractor, and the...
- This is a $18,759,457.44 federal contract awarded by the Food and Drug Administration (FDA) to Booz Allen Hamilton Inc. The contract is for contractor support services to automate and integrate the FDA's shortages workflow process. The contract is a Blanket Purchase Agreement (BPA) call under the Multiple Award Schedule (MAS) contract vehicle, which is a government-wide acquisition contract. The contract does not have a set-aside designation, indicating it was competed on a full and open...
- This is a firm fixed-price Blanket Purchase Agreement (BPA) call awarded by the Food and Drug Administration (FDA) to Booz Allen Hamilton Inc., a prominent management, technology, and engineering services firm. The contract, valued at $5,653,574.90, provides BSUFA program support services. The contract is not set aside for any specific business category and utilizes the Multiple Award Schedule (MAS) contract vehicle. Booz Allen Hamilton Inc. is the prime contractor, and the award was made on...